The Vioxx recall is just the latest of several episodes this year that have prompted criticism of the FDA and Senate hearings. A panel talks about the drug approval process, post-marketing safety surveillance, and how the agency’s work affects Americans’ health and safety.

Guests

  • Dr. Jerry Avorn author of "Powerful Medicines," professor of medicine at Harvard Medical School, and chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital in Boston
  • Sen. Charles Grassley (R-Iowa), ranking member of the Senate Finance Committee
  • Marc Kaufman reporter on the national desk of "The Washington Post"
  • Alan Goldhammer, PhD associate vice president for regulatory affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA)
  • Dr. Sandra Kweder deputy director of the FDA's Office of New Drugs

Related Links

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

Friday News Roundup – International

Friday, Dec 02 2016President-elect Trump chooses a retired Marine general to head the Pentagon. Syrian rebels agree to form a new alliance as the regime bombards Aleppo. And thousands of Cubans turn out to watch Fidel Castro's funeral procession. A panel of journalists joins Diane for analysis of the week's top international news stories.

Friday News Roundup – Domestic

Friday, Dec 02 2016President-elect Donald Trump starts a victory tour with a stop in Cincinnati. Nancy Pelosi is re-elected House minority leader. And North Carolina prosecutors say the police officer who killed Keith Lamont Scott will not face charges.

President-Elect Trump And U.S. Trade

Thursday, Dec 01 2016During the campaign President-elect Donald Trump promised to bring jobs back to the U.S. by changing the rules with our global trading partners: What stronger protectionist policies could mean for American workers and the U.S. economy.